Human Chorionic Gonadotropin (HCG) Market Research and Forecast Report 2023-2028

1. Global Human Chorionic Gonadotropin (HCG) Market Research and Forecast Report 2023-2028 Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group © 2019 IMARC All Rights Reserved

2. Report DescriptionAbout IMARC Group The International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

3. Report Description and Highlights Report Description Global Human Chorionic Gonadotropin (HCG) Market Research Report: The latest report by IMARC, titled “Human Chorionic Gonadotropin (HCG) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” the global human chorionic gonadotropin (HCG) market size reached US$ 903.78 Million in 2022. Human chorionic gonadotropin (HCG) refers to a hormone made by the placenta during pregnancy. It is essential for maintaining the production of other hormones, including progesterone and estrogen, which are necessary for a healthy pregnancy. It is responsible for supporting the development of the fertilized egg and the formation of the placenta. It helps in the nourishment of the growing embryo by ensuring the production of essential hormones until the placenta is fully formed and can take over hormone production. Request Free Sample Report: https://www.imarcgroup.com/human-chorionic-gonadotropin- market/requestsample

4. Report Description and Highlights Report Description Global Human Chorionic Gonadotropin (HCG) Market Trends: The surging prevalence of polycystic ovary syndrome (PCOS), hypothalamic dysfunction, and premature ovarian insufficiency (POI) that can disrupt normal ovulation represents one of the major factors driving the demand for HCG around the world. Moreover, HCG is used in pregnancy detection test kits to detect pregnancy through urine and blood tests. This, coupled with the increasing awareness among people about the availability of pregnancy detection kits, rising birth rate, and the growing adolescent pregnancy rate, is influencing the market positively. In addition, the increasing use of HCG to improve testosterone levels, enhance fertility, and promote sexual function is favoring the growth of the market. Apart from this, the rising usage of HCG in veterinary medicine for reproductive purposes, such as in breeding programs for animals, is propelling the market growth. Looking forward, the market value is projected to reach US$ 1,411.06 Million by 2028, expanding at a CAGR of 7.62% during 2023-2028. Looking forward, the market value is projected to reach a strong growth during the forecast period (2023-2028).

5. Report Description and Highlights Report Description Market Summary: Technology Insights: • Natural Source Extraction • Recombinant Technology Therapeutic Area Insights: • Female Infertility Treatment • Male Hypogonadism • Oligospermic Treatment • Others End User Insights: • Fertility Clinics • Research Institutions • Others Regional Insights: • North America • United States

6. Report Description and Highlights Report Description • Canada • Europe • Germany • France • United Kingdom • Italy • Spain • Russia • Others • Asia Pacific • China • Japan • India • South Korea • Australia • Indonesia • Others • Latin America • Brazil • Mexico • Others • Middle East and Africa

7. Report Description and Highlights Report Description Competitive Landscape with Key Players: • • • • • • • • • Biocare Medical LLC Ferring Pharmaceuticals Fresenius SE & Co. KGaA Kamiya Biomedical Company (Nitto Boseki Co. Ltd.) Lee Biosolutions Inc. (Oy Medix Biochemica Ab) Merck & Co. Inc. Prospec-Tany Technogene Ltd. Scripps Laboratories Inc. Sun Pharmaceutical Industries Limited View Full Report with TOC & List of Figure: https://www.imarcgroup.com/human-chorionic- gonadotropin-market

8. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

9. We are the trusted business partners to the world's leading corporates, governments, and institutions Partial List of Clients A partial List of our Clients

10. Report Description and Highlights Report Description © 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

11. Contact Us FOR MORE DETAILS Visit us at : https://www.imarcgroup.com Stay With Us: TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com